DaVita Q1 2026 adj EPS $2.87 vs $2.00 YoY; revenue $3.416B, repurchased 3M shares

DAVITA INC.

2026-Q1 EPS reported $2.87 revenue$3,415,548,000

GAAP and adjusted diluted EPS $2.87, up 44% YoY from $2.00; down sequentially from $3.40 in Q4 2025.
Consolidated revenue $3.416B; operating income $482M; operating cash flow $321M; free cash flow $140M.
Repurchased 3.0M shares at avg price $133.70 per share during Q1 2026.
CEO Javier Rodriguez highlighted clinical excellence and durable results; net income from continuing ops $198M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DAVITA INC. reported the quarter ended March 31, 2026 results: revenue $3.416 billion, net income $198 million, EPS $2.87.

Period: the quarter ended March 31, 2026
Revenue: $3.416 billion
Net income: $198 million
EPS: $2.87
Result: reported results

Exact text from the filing

strong financial performance, and this quarter is no exception.” Financial and operating highlights for the quarter and year ended March 31, 2026: • Consolidated revenues were $3.416 billion. • Operating income was $482 million. • Diluted earnings per share from continuing operations was $2.87. • Operating cash flow was $321 million and free cash flow was $140

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

DAVITA INC. filing history →

Source: SEC EDGAR

accession 0000927066-26-000060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.